Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience Corp (TWST)
NASDAQ:TWST
TWST Stock Chart & Stats
Day’s Range― - ―
52-Week Range$24.28 - $55.33
Previous CloseN/A
Volume152.02K
Average Volume (3M)1.61M
Market Cap
$1.67B
Enterprise Value$2.08B
Total Cash (Recent Filing)$250.80M
Total Debt (Recent Filing)$78.15M
Price to Earnings (P/E)―
Beta2.50
Next Earnings
Nov 24, 2025EPS Estimate
-0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.33
Shares Outstanding60,360,924
10 Day Avg. Volume1,650,281
30 Day Avg. Volume1,605,462
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.24
Enterprise Value/Revenue5.73
Enterprise Value/Gross Profit11.65
Enterprise Value/Ebitda-16.83
Forecast
1Y Price Target
$37.88Price Target Upside42.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Bulls Say, Bears Say
Bulls Say
Financial PerformanceNGS drove the quarter, delivering $55M and beating expectations.
Growth StrategyManagement signaled a shift in focus back to top-line growth, including new product launches intended to expand the SynBio market opportunity.
ProfitabilityProfitability was well ahead of expectations.
Bears Say
Macro EnvironmentMacro headwinds have impacted new customer ramps and project orders for existing customers.
Market ReactionTWST shares were down sharply (-10.3% vs. XBI +1%) in response to the F3Q meet and narrowing of guide.
Revenue GuidanceTWST narrowed their guide downward to $374M-$376M from $372M-$379M.
Twist Bioscience News
TWST FAQ
What was Twist Bioscience Corp’s price range in the past 12 months?
Twist Bioscience Corp lowest stock price was $24.28 and its highest was $55.33 in the past 12 months.
What is Twist Bioscience Corp’s market cap?
Twist Bioscience Corp’s market cap is $1.67B.
When is Twist Bioscience Corp’s upcoming earnings report date?
Twist Bioscience Corp’s upcoming earnings report date is Nov 24, 2025 which is in 86 days.
How were Twist Bioscience Corp’s earnings last quarter?
Twist Bioscience Corp released its earnings results on Aug 04, 2025. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of -$0.519 by $0.849.
Is Twist Bioscience Corp overvalued?
According to Wall Street analysts Twist Bioscience Corp’s price is currently Undervalued.
Does Twist Bioscience Corp pay dividends?
Twist Bioscience Corp does not currently pay dividends.
What is Twist Bioscience Corp’s EPS estimate?
Twist Bioscience Corp’s EPS estimate is -0.4.
How many shares outstanding does Twist Bioscience Corp have?
Twist Bioscience Corp has 60,360,924 shares outstanding.
What happened to Twist Bioscience Corp’s price movement after its last earnings report?
Twist Bioscience Corp reported an EPS of $0.33 in its last earnings report, beating expectations of -$0.519. Following the earnings report the stock price went down -10.303%.
Which hedge fund is a major shareholder of Twist Bioscience Corp?
Currently, no hedge funds are holding shares in TWST
Twist Bioscience Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$37.88 (42.46% Upside)
$37.88 (42.46% Upside)
Blogger Sentiment
Bullish
TWST Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.5%
Last 30 Days ▲ 5.8%
Last 30 Days ▲ 5.8%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.80%
12-Months-Change
Fundamentals
Return on Equity
-17.58%
Trailing 12-Months
Asset Growth
0.86%
Trailing 12-Months
Company Description
Twist Bioscience Corp
Twist Bioscience Corporation is a biotechnology company specializing in synthetic biology and DNA synthesis. Headquartered in San Francisco, California, the company focuses on providing high-quality, cost-effective DNA synthesis solutions to a variety of sectors, including pharmaceuticals, agriculture, and data storage. Twist Bioscience's core products include its synthetic DNA products, which are utilized for applications such as gene therapy, antibody discovery, and next-generation sequencing, among others.
TWST Company Deck
TWST Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a generally positive outlook with record revenue growth, significant improvements in gross margin, and strong performance in the NGS segment. However, there were challenges noted in specific regions and slower-than-expected growth in SynBio. Despite these, the company remains optimistic about future growth opportunities, especially in SynBio and NGS, and is on track to achieve adjusted EBITDA breakeven.View all TWST earnings summariesTWST Stock 12 Month Forecast
Average Price Target
$37.88
▲(42.46% Upside)
Technical Analysis
Ownership Overview
2.55% Insiders
28.03% Mutual Funds
0.02% Other Institutional Investors
41.19% Public Companies and
Individual Investors